Linezolide Arrow

Linezolid, the active ingredient in Linezolide Arrow, is a oxazolidinone presented as an oral dosage form for oral use. It treats Gram‑positive bacterial infections, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococci (VRE) in adult patients.

GNH USA supplies Linezolide Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibacterial that targets serious Gram‑positive infections. - Gram‑positive bacterial infections: provides effective bacterial clearance in infections caused by susceptible organisms. - Methicillin‑resistant Staphylococcus aureus (MRSA): achieves clinical cure in skin, soft‑tissue and pneumonia cases. - Vancomycin‑resistant Enterococci (VRE): offers an alternative therapeutic option when vancomycin is ineffective.

Linezolid may cause a range of adverse reactions, which are generally categorized as common or serious.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Metallic taste: altered taste sensation. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: numbness or tingling in extremities. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Optic neuritis: vision changes requiring urgent evaluation. - Anemia: reduction in red blood cell count.

When prescribing Linezolide Arrow, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: monitor renal function and adjust therapy if needed. - Hepatic impairment: assess liver enzymes regularly. - Concomitant serotonergic agents: evaluate risk of serotonin syndrome. - Long‑term therapy: perform periodic complete blood counts. - Pregnancy and lactation: weigh benefits against potential risks. - Store below 25°C: keep in the original pack, protect from moisture.

Linezolid can interact with other medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - SSRIs and other serotonergic drugs: risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): potential hypertensive crisis. - Rifampicin: may reduce linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Macrolide antibiotics (e.g., erythromycin): may raise linezolid levels. - Antacids containing magnesium or aluminum: could affect absorption of linezolid.